Phase 2a Study of PBTZ169

NCT03334734 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Very slow enrollment

Conditions

Tuberculosis

Interventions

DRUG: PBTZ169
DRUG: Isoniazid

Sponsor

Nearmedic Plus LLC

Collaborators

[object Object]